sciore-research-private-limited Research by SuperAGI

Company Profile: Sciore Research Private Limited

Background

Overview

Sciore Research Private Limited is a private research and development (R&D) company incorporated on July 25, 2019, in Pune, Maharashtra, India. The company specializes in contract research services, focusing on toxicity testing, pharmacology, efficacy testing, animal cell culture, microbiology, biocompatibility, genotoxicity, and biodegradation testing. Sciore Research serves a wide range of industries, including pharmaceuticals and biotechnology.

Mission and Vision

While specific mission and vision statements are not publicly available, Sciore Research is committed to providing advanced research services that adhere to the highest standards of quality and compliance, aiming to support the development of safe and effective pharmaceutical and biotechnology products.

Primary Area of Focus

The company's primary focus is on contract research services, offering comprehensive testing solutions to assess the safety and efficacy of products in the pharmaceutical and biotechnology sectors.

Industry Significance

As a contract research organization (CRO), Sciore Research plays a crucial role in the R&D ecosystem by providing essential testing services that facilitate the development of new medical treatments and technologies.

Key Strategic Focus

Core Objectives

Comprehensive Testing Services: Offer a wide range of testing services, including toxicity testing, pharmacology, efficacy testing, animal cell culture, microbiology, biocompatibility, genotoxicity, and biodegradation testing.

Quality and Compliance: Ensure all research services meet the highest standards of quality and adhere to regulatory compliance requirements.

Specific Areas of Specialization

Toxicity Testing: Assess the potential harmful effects of substances.

Pharmacology and Efficacy Testing: Evaluate the therapeutic effects and effectiveness of pharmaceutical compounds.

Animal Cell Culture and Microbiology: Conduct in vitro studies to understand biological processes and microbial interactions.

Biocompatibility and Genotoxicity Testing: Determine the compatibility of materials with biological systems and assess genetic toxicity.

Biodegradation Testing: Analyze the environmental impact and degradation rates of substances.

Key Technologies Utilized

Sciore Research employs state-of-the-art technologies and instruments in its research facilities, including advanced in vivo and in vitro testing methods, to provide accurate and reliable results.

Primary Markets Targeted

The company primarily targets the pharmaceutical and biotechnology industries, offering essential research services that support the development of new medical treatments and technologies.

Financials and Funding

Funding History

Specific details regarding the total funds raised and recent funding rounds are not publicly available.

Notable Investors

Information about individual investors is not publicly disclosed.

Utilization of Capital

While specific utilization details are not available, it is likely that the capital is used to enhance research capabilities, acquire advanced equipment, and expand service offerings to meet industry demands.

Pipeline Development

Key Pipeline Candidates

As a contract research organization, Sciore Research does not develop its own pharmaceutical products but provides testing services for clients' products in various stages of development.

Stages of Clinical Trials or Product Development

The company supports clients at various stages of product development, including preclinical and clinical phases, by providing essential testing services.

Target Conditions

The testing services offered are applicable to a wide range of conditions, depending on the clients' products under development.

Anticipated Milestones

Milestones are typically defined by the clients' product development timelines, with Sciore Research providing timely and accurate testing results to support these milestones.

Technological Platform and Innovation

Proprietary Technologies

Sciore Research utilizes advanced technologies and instruments in its research facilities, including accredited animal research facilities equipped with modern testing equipment.

Significant Scientific Methods

In Vivo and In Vitro Testing: Employs both in vivo (animal-based) and in vitro (cell-based) testing methods to assess the safety and efficacy of substances.

Biocompatibility and Genotoxicity Assessments: Conducts tests to evaluate the compatibility of materials with biological systems and to assess genetic toxicity.

Biodegradation Studies: Performs analyses to understand the environmental impact and degradation rates of substances.

AI-Driven Capabilities

There is no publicly available information indicating the use of AI-driven capabilities in Sciore Research's operations.

Leadership Team

Key Executives

Bhagyashri Eknath Nagarkar: Director

Anand Baban Rahigude: Director

Eknath Baburao Nagarkar: Director

Professional Backgrounds

Specific professional backgrounds of the directors are not publicly disclosed.

Key Contributions

The directors are responsible for overseeing the company's strategic direction, ensuring compliance with regulatory standards, and maintaining high-quality research services.

Competitor Profile

Market Insights and Dynamics

The contract research organization (CRO) market is characterized by a growing demand for outsourced research services in the pharmaceutical and biotechnology industries. This trend is driven by the need for specialized expertise, cost efficiency, and accelerated product development timelines.

Competitor Analysis

While specific competitors are not identified in the available information, Sciore Research operates in a competitive landscape with other CROs offering similar services. The company's focus on quality, compliance, and comprehensive testing services positions it to effectively compete in this market.

Strategic Collaborations and Partnerships

Significant Collaborations

Sciore Research has established partnerships with various institutions, including:

Sinhgad College of Pharmacy, Vadgaon (BK), Pune: An MoU was signed in 2022 for a duration of 5 years.

Strategic Collaborations and Partnerships

These collaborations aim to enhance research capabilities, provide training opportunities, and support the development of new pharmaceutical and biotechnology products.

Operational Insights

Strategic Considerations

Sciore Research's strategic focus on quality and compliance, coupled with its comprehensive range of testing services, enables it to meet the diverse needs of clients in the pharmaceutical and biotechnology industries.

Competitive Advantages

Accredited Facilities: The company's research facilities are accredited by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), ensuring adherence to ethical standards.

Comprehensive Service Offering: Provides a wide array of testing services, allowing clients to fulfill multiple research requirements through a single provider.

Strategic Opportunities and Future Directions

Strategic Roadmap

Sciore Research aims to expand its service offerings, enhance research capabilities, and strengthen collaborations with academic and industry partners to support the evolving needs of the pharmaceutical and biotechnology sectors.

Future Business Directions

The company is focused on maintaining high standards of quality and compliance, exploring new research methodologies, and investing in advanced technologies to stay competitive in the CRO market.

Opportunities for Expansion

Potential areas for expansion include offering additional specialized testing services, entering new geographic markets, and developing proprietary research methodologies to attract a broader client base.